September 5-9, 2020: ERS International Congress 2020 Virtual Event

Posted on 05 juin 2020, English, Italiano, Deutsch, Event, French

September 5-9, 2020: ERS International Congress 2020 Virtual Event

COSMED will attend the European Respiratory Society (ERS) International Congress Virtual Event from 5 to 9 September 2020.

September 1-4, 2020: 27th European Virtual Congress on Obesity

Posted on 04 juin 2020, English, Italiano, Deutsch, Event, French

September 1-4, 2020: 27th European Virtual Congress on Obesity

COSMED will attend the European and International Virtual Congress on Obesity - ECO ICO from 1 to 4 September 2020.

July 03, 2020: SISMES Webinar "Procedure per l’esecuzione di test da sforzo nell’era del COVID-19"

Posted on 29 mai 2020, English, Italiano, Deutsch, Event, French

July 03, 2020: SISMES Webinar

Venerdì 3 luglio COSMED partecipa al webinar organizzato dal gruppo di lavoro SISMES con un intervento su “Utilizzo dei filtri antivirali durante i test da sforzo: analisi e risultati”.

February 16, 2020: COSMED acquires Innovision ApS Technology to expand presence in the Nordic market

Posted on 16 février 2020, English, Italiano, Company, Deutsch, French

February 16, 2020: COSMED acquires Innovision ApS Technology to expand presence in the Nordic market

COSMED Announces Acquisition of Innovision Technology to Expand Product Portfolio and Presence in the Nordic Markets.

COSMED headquartered in Rome, Italy, leading manufacturer of Metabolic and Body composition technologies, has acquired assets of Innovision ApS, a Danish Company with significant know-how and expertise in the design of products for Hemodynamic (Cardiac Output), Ventilation Heterogeneity (Lung Clearance Index) and Metabolic measurements (VO2Max).

February 13, 2020: COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.

Posted on 14 février 2020, English, Italiano, Company, Deutsch, French

February 13, 2020: COSMED announces U.S. FDA 510(K) clearance of Q-NRG+ and Q-NRG Indirect Calorimetry device.

COSMED is glad to announce the U.S. Food and Drug Administration (FDA) clearance of Q-NRG+ and Q-NRG, a metabolic monitoring device utilizing Indirect Calorimetry (IC) technology intended for the measurement of Resting Energy Expenditure (REE) in patients who are mechanically ventilated or spontaneously breathing.

<<  1 2 3 4 [56 7 8 9  >>